Posted inCardiology news
Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF Trial
This trial evaluated whether atrioventricular node ablation improves outcomes of cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation, finding no significant benefit over medical rate control.
